| More
Information |
|
|
| Name |
|
|
|
| Address |
|
|
|
| District |
|
|
|
| State |
|
|
|
| Country |
|
|
|
| Category |
|
|
|
| Title |
First People’s Festival of Innovation November 19-29, 2022: Deep Tech Company’s profiles |
|
|
| Abstract |
|
|
|
| Details |
"Naayom: Indigenous technologies for mushroom farming
Company: Naayom Tech Private Limited
Email: Prasannj@gmail.com
Founders: Prasann Jain, Bharat Jajoria, & Ayush Nemani
Problem Addressed: The yield of Mushroom farming is very sensitive to environmental parameters like CO2 concentration, temperature, and humidity.
Imported mushroom computers (INR more than 5 lacs) are affordable for large farms only but can be used for maximizing the yield and minimizing operating costs.
Naayom’s indigenous developed mushroom computer costs a fraction of such imported and expensive products.
Technology: • Developed a hardware and software ecosystem to continuously monitor and control the climate inside a mushroom farm
• Naayom’s proprietary technology uses wifi enabled sensor and controls system to continuously monitor and adjust climate parameters to maintain optimum climate conditions
Societal Impact: • Currently available technology is expensive
and affordable to only large farms
• Naayom’s Krishi computer and other climate control systems
cost only a fraction of these
• These affordable Krishi computers can be used at most small and medium-scale mushroom farms to improve the quality and quantity of their produce.
Current Status: • Naayom has various offerings for the
varying needs of the clients
• We have already partnered with 20+ farms in India
• Our latest offering Mushroom Krishi computer, which was
launched last month, is also up and running at a client’s farm
Company Website Link: www.naayom.com
Easy & affordable Self Testing App & kit for diagnosing Chronic Kidney Diseases & Urinary Tract Infection Company: DNA Xperts Pvt Ltd
Email: ashwani@dnaxperts.com
Founders: Ashwani Kumar
Problem Addressed: • Currently, CKD & UTI patients need to go to a diagnostic lab/hospital for getting urine samples tested at least once every week for 4 weeks consecutively
• Long waiting time from test to report generation (at least
a few hours)
• Every year in India 20-30 million people get affected by
CKD & UTI, as per published reports
• Many PHCs across multiple states & districts do not have
facility of Urine tests
Technology: Deep Learning based algorithm combined with ‘App’ & ‘Strip’ for diagnosis of Chronic Kidney Disease & Urinary Tract Infection.
Societal Impact: PeeWee will have a great societal impact, especially in rural populations as primary healthcare centres are scarce, located far off, ill-equipped & not available all the time.
Women & elderlies suffering from UTI infection will find it very comfortable & convenient if they are able to do this test at home itself and will save them or their relatives from traveling to distant PHCs/Laboratories
Asha & Anganwadi workers will be crucial in helping people in villages adopt to self-test for UTI through PeeWee. So it’ll prove to be a boon for resource-limited settings like rural villages.
Current Status: The Algorithm & Strip is ready and tested on 100 patient samples
Need to do further validation on more samples App development to be completed soon
Bioengineered Liquid Cornea
Company: Pandorum Technologies Pvt. Ltd. Email: arun@pandorumtechnologies.in Founders: Tuhin Bhowmick & Arun Chandru
Problem Addressed: Tissue
Technology: Tissue engineering and regenerative medicine is an emerging platform that aims to restore the functionality of damaged tissues and organs. The cornea is the outermost layer of the eye, and a dysfunctional cornea means blindness. Pandorum’s bioengineered ‘Liquid Cornea’ induces and supports transparent regeneration of one’s own cornea and restores vision.
Societal Impact: Cornea opacity is one of the major causes of blindness worldwide, with millions waiting for clear donor tissues against the odds. National Health Policy targets to reduce the prevalence of blindness to 0.25% by 2025. Pandorum’s regenerative therapy, without the need for donor corneas, will play an impactful role in this mission to provide vision.
Current Status: • IND enabling pre-clinical studies and cGMP production are presently underway for Pandorum’s ‘Liquid Cornea’
• Human studies expected to commence in 2023-24, in India
and USA, after requisite regulatory approvals
Company Website Link: www.pandorum.com
" |
|
|
| Volume No. |
Honey Bee, 33(3-4)55-56, 2022 |
|
|
| Sout |
|
|
|
| Call Number |
|
